[from the 06/27/2016 edition of Breakthrough Tech Weekly]I found two stocks in our portfolio that are likely to face some headwinds due to Brexit related issues, Amgen (AMGN) and Bio-rad (BIO), so I recommend their immediate sales.Amgen is especially vulnerable, being a member of the Nasdaq 100 Index,… Read More
Archive
Filter
Global stock markets crashed and burned last week after the U.K. voted to leave the European Union, and it is not without reason to expect further losses over the next few days and weeks. Already the situation has become fluid with evidence of potential backtracking and softening of the rhetoric,… Read More
While the rest of the world was focused on the outcome of the “Brexit” vote last week, a couple of our Special Situations Portfolio stocks reported good news that may have been overlooked. Along with the overall decline in the stock market as a result of Great Britain’s decisions to… Read More
Following the Brexit vote, most of our holdings have declined more or less in line with the broader tech sector. Given how turbulent the global markets are, that’s really not much of a surprise. That said, two of our holdings have taken bigger hits than the others, largely thanks to… Read More
Few expected it, but it happened: The UK is out of the European Union. And while this may seem like an overwhelming and confusing event, and there is risk involved, it’s manageable. First, we hedged our portfolio with a position in the ProShares Ultrashort Biotech ETF (BIS). This has helped… Read More
Shares of Emergent Biosolutions (EBS), the producer of vaccines aimed at bio-terror microbe b. anthrax, fell as much as 25% on June 22, 2016. As best as we can tell, the decline in the shares is related to investor disappointment over a government contract for the production of BioThrax, the… Read More
One of the best things you can hope for when you start buying lesser known technology stocks is that they attract more interest, which is exactly what is happening with Trimble Navigation. Read More
Despite its erratic trading behavior, thus far Argos has lived up to our expectations in terms of achieving its business objectives. And with an additional $30 million in cash to fund its operations, we see no reason to change our long term view on the company’s growth prospects. Read More
As markets become more volatile, it’s worthwhile to consider ways to protect long term portfolio holdings as well as how to profit in down markets. Read More
These five stocks have been added to the Breakthrough Tech Profits Portfolios. Special Situations Portfolio:Buy Applied Optoelectronics (AAOI) up to $12.Buy Synaptics (SYNA) up to $75. Breakthrough Tech Portfolio:Buy Xilinx (XLNX) up to $53.Buy Amabrella (AMBA) up to $57. Smart Tech 50:Buy IBM (IBM) up to $155. Read More